Your browser doesn't support javascript.
loading
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.
Stopka, Tomás; Minarík, Lubomír; Dusilková, Nina; Pesta, Michal; Kulvait, Vojtech; Spacek, Martin; Zemanová, Zuzana; Kalousová, Marta; Jonásová, Anna.
Afiliação
  • Stopka T; Haematology Clinic, General Faculty Hospital, Prague, Czech Republic. tstopka@lf1.cuni.cz.
  • Minarík L; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic. tstopka@lf1.cuni.cz.
  • Dusilková N; Haematology Clinic, General Faculty Hospital, Prague, Czech Republic.
  • Pesta M; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic.
  • Kulvait V; Haematology Clinic, General Faculty Hospital, Prague, Czech Republic.
  • Spacek M; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic.
  • Zemanová Z; Pathophysiology, 1st Medical Faculty, Charles University, Prague, Czech Republic.
  • Kalousová M; Faculty of Mathematics & Physics, Charles University, Prague, Czech Republic.
  • Jonásová A; BIOCEV, 1st Medical Faculty, Charles University, Vestec, Czech Republic.
Blood Cancer J ; 12(7): 105, 2022 07 07.
Article em En | MEDLINE | ID: mdl-35798720
TRIAL REGISTRATION: GA trial is registered under EudraCT#: 2013-001639-38.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article